跳至主要内容
临床试验/NCT05671055
NCT05671055已完成不适用

CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis

icometrix10 个研究点 分布在 3 个国家目标入组 300 人开始时间: 2023年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300
试验地点
10
主要终点
Neuro-QoL cognitive

研究概览

简要总结

The present study will investigate the correlation between objective and subjective cognition in multiple sclerosis. The study will also investigate the impact of covariates such as fatigue and depression, the relationship with the Expanded Disability Status Scale (EDSS) and brain volumetrics as measured on magnetic resonance imaging (MRI). Additionally, the study will provide insights into patients' experiences with cognition, and the usability of the used objective cognitive assessments.

详细描述

Cognitive impairment is a significant burden that affects 43 to 70% of persons with multiple sclerosis (pwMS) 1. Cognitive problems have been observed in the earliest stages of multiple sclerosis (MS) and multiple studies have provided evidence for the predictive value of early cognitive impairment for future disease progression 2-6. However, cognitive function is not often discussed with pwMS or routinely assessed by healthcare providers (HCPs) leading to sub-optimal treatment of cognitive problems in MS 7. Furthermore, cognitive dysfunction that can be reliably detected by objective measures is poorly recognized by pwMS, resulting in a disconnect between objective and subjective measures of cognitive function 8-10.

The present study will investigate the correlation between what cognitive problems people with MS perceive and what objective cognitive testing actually shows. This study will also provide insights about the presence of this disconnect in different strata of the Expanded Disability Status Scale (EDSS) 11, and the relationship with possible confounders (MS symptoms, fatigue, etc.) and brain volumetrics as measured on magnetic resonance imaging (MRI).

Study Design:

CogMS is an observational, cross-sectional, remote, real-world study of cognitive function in patients with multiple sclerosis. We will investigate the correlation between subjective and objective patient self-evaluations of cognitive function while also investigating the prevalence of objective cognitive impairment in different EDSS strata of pwMS. MS patients will be stratified by EDSS to evaluate the correlation between objective and subjective cognition in three different EDSS strata (EDSS 0 - 2; 2.5 - 3.5; 4.0 - 5.5) and the occurrence of objective cognitive dysfunction in these EDSS stages of MS.

All data will be captured using the icompanion app in a remote, non-clinical setting (i.e., patient's home) within three weeks of patient onboarding. In the icompanion app, patients will be asked to perform the icognition cognitive test battery together with patient-reported outcomes (PROs) for subjective cognition, MS symptoms, prEDSS, depression and fatigue. If available, a recent (max. 6 months) MRI scan will be provided from which volumetric measurements can be calculated using icometrix' icobrain software.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Providing a signed informed consent
  • Aged between 18 and 65 years old
  • MS diagnosis (CIS, RRMS)
  • Absence of hand function problems which limit the use of a device like a smartphone
  • No history of relapse with onset 30 days prior to start of study
  • No other major neurological or psychiatric disorders
  • No history of cognitive rehabilitation treatment

排除标准

  • Disease duration longer than 15 years
  • Patients with established cognitive disorders other than MS
  • Drug and/or alcohol abuse

结局指标

主要结局

Neuro-QoL cognitive

时间窗: Single cross-sectional time-point (max 2 months after signing ICF)

The Neuro-QoL (Quality of Life in Neurological Disorders) is a patient-reported outcome for subjective cognitive problems Minimum and maximum values: 8-40 (t-score: 17.3-64.2). High scores indicate better (desirable) self-reported health.

icognition Dot test score

时间窗: Single cross-sectional time-point (max 2 months after signing ICF)

The icognition Dot test score is a smartphone-based test for visual working memory Minimum and maximum values: to be determined by a separate study which is being finalised High scores indicate better (desirable) self-reported health.

icognition Symbol test score

时间窗: Single cross-sectional time-point (max 2 months after signing ICF)

The icognition Symbol test is a smartphone-based symbol substitution test for information processing speed Minimum and maximum values: to be determined by a separate study which is being finalised High scores indicate better (desirable) self-reported health.

icognition Digit test score

时间窗: Single cross-sectional time-point (max 2 months after signing ICF)

The icognition Digit test score is a smartphone-based test for working memory Minimum and maximum values: to be determined by a separate study which is being finalised High scores indicate better (desirable) self-reported health.

次要结局

  • Neuro-QoL fatigue(Single cross-sectional time-point (max 2 months after signing ICF))
  • Beck's depression inventory(Single cross-sectional time-point (max 2 months after signing ICF))
  • System usability score (cognitive smartphone-based tests)(Single cross-sectional time-point (max 2 months after signing ICF))
  • prEDSS(Single cross-sectional time-point (max 2 months after signing ICF))
  • MRI volumetric variables(at time of enrolment in study (in case MRI of <6months is available))
  • Preference icognition vs. paper-based assessments(Single cross-sectional time-point (max 2 months after signing ICF))
  • SymptoMScreen(Single cross-sectional time-point (max 2 months after signing ICF))

研究者

发起方
icometrix
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验